{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:02:23Z","timestamp":1761156143896,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T00:00:00Z","timestamp":1468540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32 AR055885","T32AR055885-04"],"award-info":[{"award-number":["T32 AR055885","T32AR055885-04"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 DE018750","R01 AR056215"],"award-info":[{"award-number":["R21 DE018750","R01 AR056215"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00198-016-3704-6","type":"journal-article","created":{"date-parts":[[2016,7,15]],"date-time":"2016-07-15T11:19:36Z","timestamp":1468581576000},"page":"239-244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with fractures in HIV-infected persons: which factors matter?"],"prefix":"10.1007","volume":"28","author":[{"given":"L.","family":"Gedmintas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Losina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,15]]},"reference":[{"issue":"17","key":"3704_CR1","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","volume":"20","author":"TT Brown","year":"2006","unstructured":"Brown TT, Qaqish RB (2006) Antiretroviral therapy and the prevalence of osteopeania and osteoporosis: a meta-analytic review. AIDS 20(17):2165\u20132174","journal-title":"AIDS"},{"issue":"9","key":"3704_CR2","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1210\/jc.2008-0828","volume":"93","author":"VA Triant","year":"2008","unstructured":"Triant VA, Brown TT, Lee H, Grinspoon SK (2008) Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 93(9):3499\u20133504","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3704_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017217","volume":"6","author":"JA Womack","year":"2011","unstructured":"Womack JA, Goulet JL, Gibert C et al (2011) Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS ONE 6(2), e17217","journal-title":"PLoS ONE"},{"issue":"8","key":"3704_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/cid\/ciq242","volume":"52","author":"B Young","year":"2011","unstructured":"Young B, Dao CN, Buchacz K, Baker R, Brooks JT (2011) Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 52(8):1061\u20131068","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3704_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/QAD.0b013e32834ed8a7","volume":"26","author":"AB Hansen","year":"2012","unstructured":"Hansen AB, Gerstoft J, Kronborg G et al (2012) Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS 26(3):285\u2013293","journal-title":"AIDS"},{"issue":"6","key":"3704_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/jbmr.1874","volume":"28","author":"R Guerri-Fernandez","year":"2013","unstructured":"Guerri-Fernandez R, Vestergaard P, Carbonell C et al (2013) HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res 28(6):1259\u20131263","journal-title":"J Bone Miner Res"},{"issue":"5 Suppl 3","key":"3704_CR7","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1016\/j.amepre.2012.07.032","volume":"43","author":"KJ Horvath","year":"2012","unstructured":"Horvath KJ, Eastman M, Prosser R, Goodroad B, Worthington L (2012) Addressing smoking during medical visits: patients with human immunodeficiency virus. Am J Prev Med 43(5 Suppl 3):S214\u2013S221","journal-title":"Am J Prev Med"},{"issue":"4","key":"3704_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s10461-008-9449-2","volume":"14","author":"JM Tesoriero","year":"2010","unstructured":"Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE (2010) Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 14(4):824\u2013835","journal-title":"AIDS Behav"},{"issue":"6","key":"3704_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1086\/339042","volume":"34","author":"KE Sherman","year":"2002","unstructured":"Sherman KE, Rouster SD, Chung RT, Rajicic N (2002) Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 34(6):831\u2013837","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3704_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/archinte.166.1.64","volume":"166","author":"B Lau","year":"2006","unstructured":"Lau B, Sharrett AR, Kingsley LA et al (2006) C-reactive protein is a marker for human immunodeficiency virus disease progression. Arch Intern Med 166(1):64\u201370","journal-title":"Arch Intern Med"},{"issue":"4","key":"3704_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks SG, Tracy R, Douek DC (2013) Systemic effects of inflammation on health during chronic HIV infection. Immunity 39(4):633\u2013645","journal-title":"Immunity"},{"issue":"22","key":"3704_CR12","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1001\/archinte.166.22.2495","volume":"166","author":"G Schett","year":"2006","unstructured":"Schett G, Kiechl S, Weger S et al (2006) High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 166(22):2495\u20132501","journal-title":"Arch Intern Med"},{"issue":"31","key":"3704_CR13","doi-asserted-by":"publisher","first-page":"13848","DOI":"10.1073\/pnas.1003020107","volume":"107","author":"T Vikulina","year":"2010","unstructured":"Vikulina T, Fan X, Yamaguchi M et al (2010) Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats. Proc Natl Acad Sci U S A 107(31):13848\u201313853","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"3704_CR14","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","volume":"24","author":"A Bonjoch","year":"2010","unstructured":"Bonjoch A, Figueras M, Estany C et al (2010) High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS 24(18):2827\u20132833","journal-title":"AIDS"},{"issue":"11","key":"3704_CR15","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1086\/644785","volume":"200","author":"A Calmy","year":"2009","unstructured":"Calmy A, Fux CA, Norris R et al (2009) Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis 200(11):1746\u20131754","journal-title":"J Infect Dis"},{"issue":"7","key":"3704_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","volume":"23","author":"C Duvivier","year":"2009","unstructured":"Duvivier C, Kolta S, Assoumou L et al (2009) Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS 23(7):817\u2013824","journal-title":"AIDS"},{"issue":"12","key":"3704_CR17","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"GA McComsey","year":"2011","unstructured":"McComsey GA, Kitch D, Daar ES et al (2011) Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202. J Infect Dis 203(12):1791\u20131801","journal-title":"J Infect Dis"},{"issue":"8","key":"3704_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1086\/656417","volume":"51","author":"HJ Stellbrink","year":"2010","unstructured":"Stellbrink HJ, Orkin C, Arribas JR et al (2010) Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 51(8):963\u2013972","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3704_CR19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/QAD.0b013e328351997f","volume":"26","author":"LM Mundy","year":"2012","unstructured":"Mundy LM, Youk AO, McComsey GA, Bowlin SJ (2012) Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population. AIDS 26(9):1073\u20131082","journal-title":"AIDS"},{"issue":"7","key":"3704_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","volume":"26","author":"R Bedimo","year":"2012","unstructured":"Bedimo R, Maalouf NM, Zhang S, Drechsler H, Tebas P (2012) Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. AIDS 26(7):825\u2013831","journal-title":"AIDS"},{"issue":"17","key":"3704_CR21","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1097\/QAD.0b013e32833f6294","volume":"24","author":"MT Yin","year":"2010","unstructured":"Yin MT, Shi Q, Hoover DR et al (2010) Fracture incidence in HIV-infected women: results from the Women\u2019s Interagency HIV Study. AIDS 24(17):2679\u20132686","journal-title":"AIDS"},{"issue":"3","key":"3704_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/QAI.0b013e31821ecf4c","volume":"57","author":"MK Yong","year":"2011","unstructured":"Yong MK, Elliott JH, Woolley IJ, Hoy JF (2011) Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients. J Acquir Immune Defic Syndr 57(3):205\u2013210","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3704_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1210\/jc.2013-2194","volume":"99","author":"L Gedmintas","year":"2014","unstructured":"Gedmintas L, Wright EA, Losina E, Katz JN, Solomon DH (2014) Comparative risk of fracture in men and women with HIV. J Clin Endocrinol Metab 99(2):486\u2013490","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3704_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/art.30653","volume":"64","author":"DH Solomon","year":"2012","unstructured":"Solomon DH, Mercer E, Kavanaugh A (2012) Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results. Arthritis Rheum 64(1):21\u201332","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3704_CR25","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jama.2013.1099","volume":"309","author":"KL Winthrop","year":"2013","unstructured":"Winthrop KL, Baddley JW, Chen L et al (2013) Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA 309(9):887\u2013895","journal-title":"JAMA"},{"issue":"Suppl 3","key":"3704_CR26","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1007\/BF01623005","volume":"3","author":"DM Black","year":"1993","unstructured":"Black DM, Reiss TF, Nevitt MC, Cauley J, Karpf D, Cummings SR (1993) Design of the Fracture Intervention Trial. Osteoporos Int 3(Suppl 3):S29\u2013S39","journal-title":"Osteoporos Int"},{"key":"3704_CR27","unstructured":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services: Panel on Antiretroviral Guidelines for Adults and Adolescents"},{"issue":"9","key":"3704_CR28","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1097\/QAD.0000000000001067","volume":"30","author":"JL Casado","year":"2016","unstructured":"Casado JL, Santiuste C, Vazquez M, Baon S, Rosillo M, Gomez A, Perez-Elias MJ, Cabellero C, Rey JM, Moreno S (2016) Bone mineral density decline according to renal tubular dysfunction and phosphaturia in tenofovir-exposed HIV-infected patients. AIDS 30(9):1423\u20131431","journal-title":"AIDS"},{"issue":"9987","key":"3704_CR29","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","volume":"385","author":"PE Sax","year":"2015","unstructured":"Sax PE, Wohl D, Yin MT et al (2015) Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials. Lancet 385(9987):2606\u20132615","journal-title":"Lancet"},{"issue":"14","key":"3704_CR30","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/QAD.0000000000000363","volume":"28","author":"HV Dong","year":"2014","unstructured":"Dong HV, Cortes YI, Shiau S, Yin MT (2014) Osteoporosis and fractures in HIV\/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS 28(14):2119\u20132131","journal-title":"AIDS"},{"key":"3704_CR31","unstructured":"Cutrell J, Zhang S, Drechsler H, Tebas P, Maalouf N, Bedimo R (2015) Evaluation and management of fracture risk in HIV patients in the VA system. International AIDS Society; Vancouver, Canada"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3704-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3704-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3704-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:37:20Z","timestamp":1589441840000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3704-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3704"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3704-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2016,7,15]]},"assertion":[{"value":"7 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Partners Human Research Committee.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Solomon has received salary support from research contracts to Brigham and Women\u2019s Hospital from Amgen, Eli Lilly, and CORRONA. He has also served in unpaid roles on studies sponsored by Pfizer, Novartis, Lilly, and Bristol Myers Squibb. He receives royalties from UpToDate. He is deputy editor of Arthritis and Rheumatology. Drs. Katz and Losina are deputy editors of the Journal of Bone and Joint Surgery. Dr. Katz is president-elect of the Osteoarthritis Research Society International. Dr. Gedmintas served in an unpaid role in a study sponsored by Pfizer. Elizabeth Wright, Yan Dong, and Eliyahu Lehmann declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}